Literature DB >> 1855981

Experimental Staphylococcus aureus arthritis in mice.

T Bremell1, S Lange, A Yacoub, C Rydén, A Tarkowski.   

Abstract

Staphylococcus aureus arthritis is usually caused by bacteremia and is highly destructive. Controlled studies on septic arthritis in humans are difficult to perform, because the time of onset of the infection is unknown. Animal models of bacterial arthritis make it possible to control important variables in experimental studies. We present a mouse model of S. aureus arthritis in which the intravenous administration of 10(7) cells of S. aureus LS-1 induced arthritis or osteitis or both within 3 weeks in 80 to 90% of the mice. Signs of arthritis emerged within the first few days after the injection. An interesting finding was that the S. aureus strain used in this study binds bone sialoprotein, a glycoprotein known to be specifically localized to bone tissue. This new model of S. aureus arthritis enables the study of the kinetics of joint destruction and the host-bacterium relationship as well as therapeutical approaches to septic arthritis and osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855981      PMCID: PMC258064          DOI: 10.1128/iai.59.8.2615-2623.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  SYNOVITIS IN RABBITS DURING BACTEREMIA AND VACCINATION.

Authors:  G W LEWIS; L E CLUFF
Journal:  Bull Johns Hopkins Hosp       Date:  1965-03

2.  A new solid-state reagent to iodinate proteins. I. Conditions for the efficient labeling of antiserum.

Authors:  M A Markwell
Journal:  Anal Biochem       Date:  1982-09-15       Impact factor: 3.365

3.  Specific binding of collagen to Staphylococcus aureus.

Authors:  D Holderbaum; R A Spech; L A Ehrhart
Journal:  Coll Relat Res       Date:  1985-06

4.  Rapid methods for isolation of human plasma fibronectin.

Authors:  S I Miekka; K C Ingham; D Menache
Journal:  Thromb Res       Date:  1982-07-01       Impact factor: 3.944

5.  Experimental study of acute suppurative bone and joint infection. II. Suppurative arthritis.

Authors:  Y Z Wang; J C Xu; D M Xue
Journal:  Chin Med J (Engl)       Date:  1983-12       Impact factor: 2.628

6.  Experimental model of type IV Streptococcus agalactiae (group B streptococcus) infection in mice with early development of septic arthritis.

Authors:  L Tissi; P Marconi; P Mosci; L Merletti; P Cornacchione; E Rosati; S Recchia; C von Hunolstein; G Orefici
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Infection of rabbit knee joints after intra-articular injection of Staphylococcus aureus. Comparison with joints injected with Staphylococcus albus.

Authors:  A H Johnson; W G Campbell; B C Callahan
Journal:  Am J Pathol       Date:  1970-08       Impact factor: 4.307

8.  Experimental models of bacterial arthritis: a microbiologic and histopathologic characterization of the arthritis after the intraarticular injections of Neisseria gonorrhoeae, Staphylococcus aureus, group A streptococci, and Escherichia coli.

Authors:  D L Goldenberg; P L Chisholm; P A Rice
Journal:  J Rheumatol       Date:  1983-02       Impact factor: 4.666

9.  High surface hydrophobicity of autoaggregating Staphylococcus aureus strains isolated from human infections studied with the salt aggregation test.

Authors:  A Ljungh; S Hjertén; T Wadström
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

10.  Antigen-induced experimental septic arthritis in rabbits after intraarticular injection of Staphylococcus aureus.

Authors:  M L Mahowald; L Peterson; J Raskind; D A Raddatz; R Shafer; D Gerding
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

View more
  56 in total

1.  Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance.

Authors:  I Gjertsson; O H Hultgren; A Tarkowski
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  Role of intercellular adhesion molecule 1 in pathogenesis of staphylococcal arthritis and in host defense against staphylococcal bacteremia.

Authors:  M Verdrengh; T A Springer; J C Gutierrez-Ramos; A Tarkowski
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.

Authors:  I M Nilsson; J C Lee; T Bremell; C Rydén; A Tarkowski
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 4.  Sortases and the art of anchoring proteins to the envelopes of gram-positive bacteria.

Authors:  Luciano A Marraffini; Andrea C Dedent; Olaf Schneewind
Journal:  Microbiol Mol Biol Rev       Date:  2006-03       Impact factor: 11.056

5.  Staphylococcus aureus causing osteomyelitis binds to a nonapeptide sequence in bone sialoprotein.

Authors:  C Rydén; H S Tung; V Nikolaev; A Engström; A Oldberg
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

Review 6.  Mouse models for infectious diseases caused by Staphylococcus aureus.

Authors:  Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  J Immunol Methods       Date:  2014-04-24       Impact factor: 2.303

7.  Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis.

Authors:  M Verdrengh; A Tarkowski
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

8.  Immunopathological features of rat Staphylococcus aureus arthritis.

Authors:  T Bremell; S Lange; R Holmdahl; C Rydén; G K Hansson; A Tarkowski
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Azithromycin in combination with riboflavin decreases the severity of Staphylococcus aureus infection induced septic arthritis by modulating the production of free radicals and endogenous cytokines.

Authors:  Pinky Mal; Kallol Dutta; Debasish Bandyopadhyay; Anirban Basu; Rajni Khan; Biswadev Bishayi
Journal:  Inflamm Res       Date:  2012-11-15       Impact factor: 4.575

10.  V beta 11+ T-lymphocyte expansion by toxic shock syndrome toxin-1 differs in mice bearing H-2q versus H-2b haplotypes.

Authors:  Y X Zhao; U Brunsberg; R Holmdahl; A Tarkowski
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.